parthenolide and mesalamine

parthenolide has been researched along with mesalamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fleming, A; Goldsmith, P; Jankowski, J	1
Jeong, HJ; Kim, EM; Kim, IH; Kim, SH; Kim, SL; Kim, SW; Kim, YN; Lee, SO; Lee, ST; Liu, YC; Park, YR; Seo, SY	1

Other Studies

2 other study(ies) available for parthenolide and mesalamine

Article	Year
In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study. Inflammatory bowel diseases, 2010, Volume: 16, Issue:7 Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Embryo, Nonmammalian; Feasibility Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Larva; Mesalamine; Prednisolone; Sesquiterpenes; Thalidomide; Zebrafish	2010
Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation. Molecular cancer research : MCR, 2017, Volume: 15, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Cell Proliferation; Colitis; Colorectal Neoplasms; Drug Synergism; Female; Humans; Mesalamine; Mice; Mice, Inbred BALB C; NF-kappa B; Phenylhydrazines; Sesquiterpenes; Signal Transduction	2017

Article

Year

In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.

Inflammatory bowel diseases, 2010, Volume: 16, Issue:7

Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Embryo, Nonmammalian; Feasibility Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Larva; Mesalamine; Prednisolone; Sesquiterpenes; Thalidomide; Zebrafish

2010

Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.

Molecular cancer research : MCR, 2017, Volume: 15, Issue:2

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Cell Proliferation; Colitis; Colorectal Neoplasms; Drug Synergism; Female; Humans; Mesalamine; Mice; Mice, Inbred BALB C; NF-kappa B; Phenylhydrazines; Sesquiterpenes; Signal Transduction

2017